Biogen shareholders back Susan Langer as director
(Reuters) - Biogen shareholders elected former company executive Susan Langer as a director on Monday, weeks after her romantic partner, Alex Denner, ...
Source: wkzo.com
📰 Alkermes News
Page 29 - Alkermes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alkermes. Real-time updates on events, politics, business and more.
Independent Proxy Advisory Firm ISS Agrees With Sarissa Capital That Shareholders' Interests Would Be Best Served With Direct Shareholder Representation on the Alkermes Board
Questions the integrity of Chairman and CEO Richard Pops and the accuracy of what management has communicated to the Alkermes Board Concludes that Alkermes’ leadership lacks either the ability or desire to manage its exorbitant spending Determines that absent shareholder representation on the Board, Alkermes may “squander” the “windfall” from the recent Janssen decision
New York United States Df King Co Inc Institutional Shareholder Services Inc Sarissa Capital Management Institutional Shareholder Services
Source: marketscreener.com
Independent Proxy Advisory Firm ISS Agrees With Sarissa Capital That Shareholders' Interests Would Be Best Served With Direct Shareholder Representation on the Alkermes Board | Region
GREENWICH, Conn.--(BUSINESS WIRE)--Jun 22, 2023--
United States New York Dayna Packes Df King Co Inc Institutional Shareholder Services Inc Institutional Shareholder Services
Source: eagletribune.com
Suvoda Expands Board of Directors With Addition of Clinical Trial Veteran Irena Webster
/PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous...
Comunidad Autonoma De Cataluna United States Jagath Wanninayake Irena Lerentracht Webster Mara Conklin Kathy Zoeller
Source: prnewswire.com
Independent Proxy Advisory Firm ISS Recommends Alkermes Shareholders Vote Against Sarissa Employees' Election to Alkermes Board
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) (the Company) today announced that independent shareholder advisory firm Institutional Shareholder Services (ISS)...
United States Catot Laurencin Sarah Schlesinger Christopheri Wright Brianp Mckeon Chris Kittredge Zachary Tramonti
Source: prnewswire.com
ISS recommends one of Sarissa's three nominees for Alkermes board
Proxy advisory firm Institutional Investor Services urged Alkermes shareholders to elect one of three director candidates proposed by activist hedge fund Sarissa Capital, arguing more outside... | June 20, 2023
Source: marketscreener.com
Independent Proxy Advisory Firm ISS Concludes That Sarissa Capital Has Made a Compelling Case for Change to the Alkermes Board
ISS recommends that Alkermes shareholders vote the Blue Card “FOR” the election of Sarissa nominee Dr. Sarah Schlesinger to the Alkermes board ISS recommends that Alkermes shareholders... | June 20, 2023
New York United States Richard Gaynor Df King Co Inc Sarissa Capital Management Alkerme Annual General Meeting
Source: marketscreener.com
Alkermes (NASDAQ:ALKS) Releases FY 2023 Earnings Guidance
Alkermes (NASDAQ:ALKS – Get Rating) updated its FY 2023 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $1.34-$1.57 for the period, compared to the consensus estimate of $0.75. The company issued revenue guidance of $1.55 billion-$1.68 billion, compared to the consensus revenue estimate of $1.42 billion. Analysts Set New Price […]
United States Catot Laurencin Nancy Wysenski Piper Sandler Alkermes Company Profile Jpmorgan Chase Co
Source: theenterpriseleader.com
Alkermes (NASDAQ:ALKS) Issues FY 2023 Earnings Guidance
Alkermes (NASDAQ:ALKS – Get Rating) updated its FY 2023 earnings guidance on Friday. The company provided earnings per share guidance of $1.34-$1.57 for the period, compared to the consensus earnings per share estimate of $0.75. The company issued revenue guidance of $1.55 billion-$1.68 billion, compared to the consensus revenue estimate of $1.42 billion. Analysts Set […]
Source: tickerreport.com
Alkermes and Cogent Biosciences Stock See Action From Activist Investors
Sarissa Capital is pushing for change at biopharmaceutical firm Alkermes. Fairmount Funds lifted its investment in Cogent Biosciences.
Source: biztoc.com